Skip to main content
padlock icon - secure page this page is secure
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery publishes review articles by experts on recent patents in the field of endocrine, metabolic and immune drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery.

Publisher: Bentham Science Publishers

Volume 4, Number 3, November 2010

Articles

Favourites:
ADD

Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
pp. 190-205(16)
Authors: Spuch, Carlos; Navarro, Carmen

Favourites:
ADD
Favourites:
ADD

Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia:The Role of Partial Agonists of D2 Dopaminergic Receptors
pp. 230-240(11)
Authors: De Berardis, Domenico; Acciavatti, Tiziano; Campanella, Daniela; Serroni, Nicola; Olivieri, Luigi; Ranalli, Carla; Marasco, Viviana; Carano, Alessandro; Cavuto, Marilde; Di Iorio, Giuseppe; Piersanti, Monica; S. Moschetta, Francesco; Di Giannantonio, Massimo

Favourites:
ADD

Therapeutic Approach on AGE-RAGE Interaction and Its Function in Diabetic Inflammation Process
pp. 241-247(7)
Authors: A. Veloso, Clara; M.O. Volpe, Caroline; L. Carrara, Cristina; M. Chaves, Miriam; A. Nogueira-Machado, Jose

Favourites:
ADD

Recent Patents on Oral Insulin
pp. 248-252(5)
Authors: Kalra, Sanjay; Kalra, Bharti; Agrawal, Navneet; Khare, Sandeep

Favourites:
ADD

Patent Selections
pp. 253-254(2)
Author: Bentham Science Publishers

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more